Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Dihexa is a research-stage, investigational peptide, so it is discussed for general interest rather than as a treatment for any cognitive condition
The peptide is typically administered via subcutaneous injection, and therapy may consist of two short courses per year, following either the 100mg Russian Protocol or the 50mg Ukrainian Protocol
[PMID: 12562755] PubMed record related to this compound for laboratory literature review
Real-world Response Timeline across BPC-157 Injectable Protocols Days 1 to 5: Most users reported little to no change, while some noted mild injection-site redness
Bree Foster
The practical consequence of this mechanism is that BPC-157 works best when it can physically reach the target tissue
